Cite Filings / JBIO
Feed Companies Filings Check
Sign in

CIK 0001798749

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Jade Biosciences, Inc.

Sign in to watch
Ticker
JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831377888
Phone
+1 781-312-3013
Business address
221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aerovate Therapeutics, Inc.
Filings Financials Insiders Search text
All 515 Financials 83 Shareholder Meetings 5 Executive Compensation 70 Insider Trading 214 Beneficial Ownership Interest 63 Business Combinations 83 Public Offerings 45 Mutual Funds and ETFs 4 Others 87
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2022-04-29
  3. 8-K Event ● Material agreement · New debt or obligation 2022-04-29
  4. 10-K Report Annual Report 2022-03-30
  5. 8-K Event ● Results of operations 2022-03-30
  6. 8-K Event Regulation FD disclosure 2021-12-15
  7. 8-K Event ● Results of operations 2021-11-15
  8. 8-K Event ● Results of operations 2021-08-16
  9. 8-K Event ● Material agreement · New debt or obligation 2021-08-12
  10. 8-K Event ● Executive or director change 2021-07-19
  11. 8-K Event Bylaws or fiscal year change 2021-07-02

Page 4 of 4 · 70 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…